Clinical Trial Update: A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis [Phase 2]

View source ↗

Summary

Phase II trial of MEDI-507 for adults with plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• MEDI-507

Snippet

Sponsor: MedImmune LLC | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED